Article Versions Notes

Vlot MC, Boekel L, Kragt J, Killestein J, van Amerongen BM, de Jonge R, den Heijer M, Heijboer AC. Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)₂D, but No Difference in Ratio of 25(OH)D/24,25(OH)₂D and FGF23 Concentrations. Nutrients. 2019; 11(11):2774. https://doi.org/10.3390/nu11112774

Vlot, Mariska C, Laura Boekel, Jolijn Kragt, Joep Killestein, Barbara M. van Amerongen, Robert de Jonge, Martin den Heijer, and Annemieke C. Heijboer. 2019. "Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)₂D, but No Difference in Ratio of 25(OH)D/24,25(OH)₂D and FGF23 Concentrations" Nutrients 11, no. 11: 2774. https://doi.org/10.3390/nu11112774

Vlot, M. C., Boekel, L., Kragt, J., Killestein, J., van Amerongen, B. M., de Jonge, R., den Heijer, M., & Heijboer, A. C. (2019). Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)₂D, but No Difference in Ratio of 25(OH)D/24,25(OH)₂D and FGF23 Concentrations. Nutrients, 11(11), 2774. https://doi.org/10.3390/nu11112774